The impact of the US priority review voucher on private-sector investment in global health research and development

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	PLoS neglected tropical diseases 2012-08, Vol.6 (8), p.e1750-e1750
Hauptverfasser:	Robertson, Andrew S, Stefanakis, Rianna, Joseph, Don, Moree, Melinda
Format:	Artikel
Sprache:	eng
Schlagworte:	Biomedical Research - economics Biomedical Research - trends Communicable Diseases - diagnosis Communicable Diseases - epidemiology Communicable Diseases - therapy Developing countries Economic aspects FDA approval Forecasts and trends Global Health Government finance Health Policy Humans Infection Control - methods International aspects Investments - statistics & numerical data Investments - trends LDCs Medical research Medicine, Experimental Neglected Diseases - diagnosis Neglected Diseases - epidemiology Neglected Diseases - prevention & control Neglected Diseases - therapy Policy Platform Private sector Private Sector - economics Private Sector - statistics & numerical data Private Sector - trends Product development Research - economics Research - trends Science Policy Tropical diseases United States World health
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!